In the complex landscape of modern American healthcare, a striking disconnect persists between the staggering costs of chronic disease and the strategies employed by the industry to manage them. As…
By Michael Greger, M.D., FACLM October 6, 2026 In the modern landscape of American healthcare, a paradox persists that continues to drain both national budgets and individual vitality. We live…
By Michael Greger, M.D., FACLM October 6, 2026 The modern healthcare landscape is often defined by a paradoxical struggle: while the medical community possesses the knowledge to prevent, treat, and…
In the complex landscape of modern American healthcare, a persistent question remains unanswered by the industry’s biggest players: Why is there such a profound hesitation to champion plant-based nutrition as…
The landscape of modern oncology is characterized by a paradox: as the pharmaceutical industry accelerates the production of innovative, high-priced anticancer agents, the long-term prognosis for many patients remains stubbornly…
In the high-stakes world of oncology, the introduction of a new chemotherapy drug is often heralded with significant fanfare. Terms like "game changer" and "medical breakthrough" dominate press releases and…
By Michael Greger, M.D., FACLM October 1, 2026 For years, the humble fenugreek seed has been whispered about in the fitness community, primarily as a natural, plant-based supplement for those…
In recent years, a persistent critique has emerged from corporate-funded corners of the research world: the claim that observational studies in nutrition are inherently flawed and unreliable. This argument suggests…
The intersection of industry influence and public health guidelines has long been a subject of intense scrutiny, but few moments have sparked as much outrage within the scientific community as…
In the realm of nutritional science, the integrity of research is the bedrock of public health policy. However, a pattern of recurring influence has emerged, casting a long shadow over…